Initial studies of MLE4901 indicated immediate, highly significant and sustained relief from VMS. 24 A total of 37 women were randomized to MLE4901 or to placebo.
← all excerpts
Neurokinin receptor antagonists as potential non-hormonal treatments for vasomotor symptoms of menopause.
1
—
—